Thue Johansen,Ann Marie Ocampo Francisco,Torsten Christensen,Jens Harald Kongsoe,Trine Ahlgreen
申请号：
US14888118
公开号：
US10137172B2
申请日:
2014.04.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit, as well as to kits for use in the same. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin comprises or consists of the following steps: (a) optionally providing a blood sample to be tested from an individual in need of treatment； (b) taking a single fasting blood (or plasma) glucose measurement from said individual in need of treatment； (c) using the single fasting blood (or plasma) glucose measurement to determine the insulin dose to be administered； and (d) administering the long-acting or ultra-long insulin to the individual at the dose determined in step (c).
